Amorphous Drug–Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c00942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Amy Lan Neusaenger und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States. Hauptthemen laut MEDLINE: Polymers, Protons. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States.
- Drug Product Development, Bristol Myers Squibb, Summit, New Jersey 07901, United States.
- Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53706, United States.
ORCID-Profile: Amy Lan Neusaenger, Xin Yao, Junguang Yu, Lian Yu
Förderung
- Bill and Melinda Gates Foundation
Zitieren
APA
Neusaenger, A. L., Yao, X., Yu, J., Kim, S., Hui, H. W., Huang, L., Que, C., & Yu, L. (2023). Amorphous Drug–Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c00942
Vancouver
Neusaenger AL, Yao X, Yu J, Kim S, Hui HW, Huang L, et al. Amorphous Drug–Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c00942
BibTeX
@article{Neusaenger2023,
author = {Neusaenger, Amy Lan and Yao, Xin and Yu, Junguang and Kim, Soojin and Hui, Ho-Wah and Huang, Lian and Que, Chailu and Yu, Lian},
title = {Amorphous Drug–Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c00942}
}
EUVIMED